| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |